LTRN icon

Lantern Pharma

25 hedge funds and large institutions have $10.4M invested in Lantern Pharma in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
-8
Holders Change %
-24.24%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
10
Reduced
6
Closed
11
Calls
Puts
$21K
Net Calls
-$21K
Net Calls Change
+$99K
Name Holding Trade Value Shares
Change
Shares
Change %
AFM
26
Anson Funds Management
Texas
-$519K -64,999 Closed
LCM
27
Lynwood Capital Management
Ontario, Canada
-$399K -50,000 Closed
Millennium Management
28
Millennium Management
New York
-$387K -48,558 Closed
TI
29
Trexquant Investment
Connecticut
-$223K -27,970 Closed
Two Sigma Advisers
30
Two Sigma Advisers
New York
-$202K -25,300 Closed
Citadel Advisors
31
Citadel Advisors
Florida
-$89K -11,095 Closed
JF
32
Jump Financial
Illinois
-$88K -11,028 Closed
Envestnet Asset Management
33
Envestnet Asset Management
Illinois
-$84K -10,542 Closed
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
-$83K -10,439 Closed
Bank Julius Baer & Co
35
Bank Julius Baer & Co
Switzerland
-$20K -2,500 Closed